John P. Schmid, CFO and Secretary at Trius Therapeutics Inc (TSRX), sold 700 shares at $6.00 ($4K) on 2011-05-03, disclosed to the SEC on 2011-05-03.
Scheduled sale ($4k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.62 | 500 | $3K | 70.1% |
| 2 | $6.00 | 200 | $1K | 29.9% |
| Total | $5.73 avg | 700 | $4K | 100% |
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |